The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH), are rapidly becoming among the top causes of cirrhosis, hepatocellular carcinoma, and indications for liver transplantation. Other than lifestyle modification through diet and exercise, there are currently no other approved treatments for NASH/NAFLD. Although weight loss can be effective, it is difficult to achieve and sustain. In contrast, bariatric surgery can improve metabolic conditions associated with NAFLD, and has been shown to improve liver histology. To have approved regimens for the treatment of NASH/NAFLD, several issues must be addressed. First, all stakeholders must agree on the most appropriate clinical trial endpoints for NASH. Currently, resolution of NASH (without worsening fibrosis) or reduction of fibrosis stage (without worsening NASH) are the accepted endpoints by the regulatory authorities. It is important to recognize the prognostic implication of histologic features of NASH. In this context, although histologic NASH has been associated with advanced fibrosis, it is not an independent predictor of long-term mortality. In contrast, there are significant data to suggest that fibrosis stage is the only robust and independent predictor of liver-related mortality. In addition to the primary endpoints, several important secondary endpoints, including noninvasive biomarkers, long-term outcomes, and patient-reported outcomes must be considered. In 2018, a few phase 3 clinical trials for the treatment of NASH have been initiated. Additionally, a number of phase 2a and 2b clinical trials targeting different pathogenic pathways in NASH are in the pipeline of emerging therapies. CONCLUSION: Over the next 5 years, some of these regimens are expected to provide potential new treatment options for patients with NASH/NAFLD. (Hepatology 2018;68:361-371).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationEffects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Self-citationPioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Self-citationAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Self-citationEkstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Self-citationArmstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Gastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Self-citationWen, C. P., Wai, J. P. M., Tsai, M. K., Yang, Y. C., Cheng, T. Y. D., Lee, M.-C., Chan, H. T., Tsao, C. K., Tsai, S. P., & Wu, X. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60749-6 · Cited by 1,908
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Self-citationBariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791 · cited 1×
“In addition, bariatric surgery can prevent cardiovascular events((46)) and improve type 2 diabetes.((47,48)) Regardless of the type of bariatric surgical procedure performed, a decrease in adiposity is seen after bariatric surgery.”
BackgroundMarcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Williams, M. A., Haskell, W. L., Ades, P. A., Amsterdam, E. A., Bittner, V., Franklin, B. A., Gulanick, M., Laing, S. T., & Stewart, K. J. (2007) · Circulation · doi:10.1161/circulationaha.107.185214 · Cited by 1,211
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Self-citationHagström, H., Nasr, P., Ekstedt, M., Hammar, U., Stål, P., Hultcrantz, R., & Kechagias, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.027 · Cited by 1,067
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Self-citationPathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894
Self-citationYounossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802 · cited 2×
“considered and new treatment regimens will be developed for NASH patients at risk of progressive hepatic fibrosis and its associated clinical outcomes.((1-8)) In the quest to find an effective and safe treatment for the progressive form of NAFLD or NASH, several priorities and challenges must be recognized.”
BackgroundSelf-citationBariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762
Self-citationNonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 725
Athyros, V. G., Tziomalos, K., Gossios, T. D., Griva, T., Anagnostis, P., Kargiotis, K., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., & Mikhailidis, D. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61272-x · Cited by 685
Younossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638
Self-citationGoldberg, D., Ditah, I. C., Saeian, K., Lalehzari, M., Aronsohn, A., Gorospe, E. C., & Charlton, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.003 · Cited by 604
Self-citationThoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523 · cited 4×
“Lifestyle modification that includes weight loss and structured exercise remains the cornerstone of treatment for patients with NAFLD and NASH.((20)) In this context, weight loss has been associated with a reduction in liver fat and improvement in aminotransferase levels.”
BackgroundInfluentialAerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509
Self-citationNIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
(1991) · PubMed · Cited by 496
Loomba, R., Wolfson, T., Ang, B., Hooker, J., Behling, C., Peterson, M., Valasek, M., Lin, G., Brenner, D., Gamst, A., et al. (2014) · Hepatology · doi:10.1002/hep.27362 · Cited by 489
Self-citationMathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483
Self-citationSingh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9607 · Cited by 449
D'Ambrosio, R., Aghemo, A., Rumi, M. G., Ronchi, G., Donato, M. F., Paradis, V., Colombo, M., & Bedossa, P. (2012) · Hepatology · doi:10.1002/hep.25606 · Cited by 409
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Self-citationRatziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., LeNaour, G., Hartmann-Heurtier, A., Bruckert, E., & Poynard, T. (2010) · Hepatology · doi:10.1002/hep.23270 · Cited by 366
Self-citationSanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2015) · Hepatology · doi:10.1002/hep.27678 · Cited by 354
Self-citationLoomba, R., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J., Kono, Y., Bhatt, A., et al. (2015) · Hepatology · doi:10.1002/hep.27647 · Cited by 344
Self-citationBoettcher, E., Csako, G., Pucino, F., Wesley, R., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04912.x · Cited by 318
Self-citationEffect of aerobic exercise training dose on liver fat and visceral adiposity
Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., Baker, M. K., Chuter, V. H., Caterson, I. D., George, J., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.022 · Cited by 313
Kleiner, D. E., & Makhlouf, H. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.011 · Cited by 303
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C†
Huang, H., Shiffman, M. L., Friedman, S., Venkatesh, R., Bzowej, N., Abar, O. T., Rowland, C. M., Catanese, J. J., Leong, D. U., Sninsky, J. J., et al. (2007) · Hepatology · doi:10.1002/hep.21695 · Cited by 297
Self-citationCurrent efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z., & Sanyal, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 262
Self-citationRipoll, C., Bañares, R., Rincón, D., Catalina, M.-V., Lo Iacono, O., Salcedo, M., Clemente, G., Núñez, O., Matilla, A., & Molinero, L.-M. (2005) · Hepatology · doi:10.1002/hep.20871 · Cited by 246
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Self-citationThe globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health
Rinella, M., & Charlton, M. (2016) · Hepatology · doi:10.1002/hep.28524 · Cited by 219
Self-citationWeight change and obesity after liver transplantation: Incidence and risk factors
Everhart, J. E., Lombardero, M., Lake, J. R., Wiesner, R. H., Zetterman, R. K., & Hoofnagle, J. H. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040402 · Cited by 207
Wang, X., Li, J., Riaz, D. R., Shi, G., Liu, C., & Dai, Y. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.023 · Cited by 200
Glass, L. M., Dickson, R. C., Anderson, J. C., Suriawinata, A. A., Putra, J., Berk, B. S., & Toor, A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3380-3 · Cited by 176
Kim, R. G., Loomba, R., Prokop, L. J., & Singh, S. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.039 · Cited by 174
Self-citationThe Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance
Mathurin, P., Gonzalez, F., Kerdraon, O., Leteurtre, E., Arnalsteen, L., Hollebecque, A., Louvet, A., Dharancy, S., Cocq, P., Jany, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.024 · Cited by 158
Self-citationEffect of exercise on the development of new fatty liver and the resolution of existing fatty liver
Sung, K., Ryu, S., Lee, J., Kim, J., Wild, S. H., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.026 · Cited by 156
Kargiotis, K., Athyros, V. G., Giouleme, O., Katsiki, N., Katsiki, E., Anagnostis, P., Boutari, C., Doumas, M., Karagiannis, A., & Mikhailidis, D. P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7860 · Cited by 147
Tsochatzis, E. A., Bruno, S., Isgrò, G., Hall, A. R., Theocharidou, E., Manousou, P., Dhillon, A. P., Burroughs, A. K., & Luong, T. V. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.023 · Cited by 140
Mallory body—A disease-associated type of sequestosome
Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., & Denk, H. (2002) · Hepatology · doi:10.1053/jhep.2002.32674 · Cited by 135
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4153-y · Cited by 131
Self-citationLonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., Zona, S., & Targher, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9674 · Cited by 126
Younossi, Z. M., Stepanova, M., Henry, L. L., Racila, A., Lam, B. P., Phạm, T. T. H., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13391 · Cited by 109
Self-citationDare, A. J., Plank, L. D., Phillips, A. R. J., Gane, E. J., Harrison, B., Orr, D. W., Jiang, Y., & Bartlett, A. S. J. R. (2014) · Liver Transplantation · doi:10.1002/lt.23818 · Cited by 106
Antifibrotic Therapies: Where Are We Now?
Yoon, Y., Lee, Y., & Friedman, S. L. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1571295 · Cited by 86
Self-citationFibrosis progression in chronic hepatitis C
Goodman, Z. D., Stoddard, A. M., Bonkovsky, H. L., Fontana, R. J., Ghany, M. G., Morgan, T. R. M., Wright, E. C., Brunt, E. M., Kleiner, D. E., Shiffman, M. L., et al. (2009) · Hepatology · doi:10.1002/hep.23211 · Cited by 69
Self-citationCurrent complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
Golabi, P., Sayıner, M., Fazel, Y., Koenig, A. B., Henry, L. L., & Younossi, Z. M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1099433 · Cited by 61
Self-citationTrépo, E., Potthoff, A., Pradat, P., Bakshi, R. K., Young, B. A., LAGIER, R. J., Moreno, C., Verset, L., Cross, R., Degré, D., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.018 · Cited by 57
Stepanova, M., Henry, L. L., Garg, R., Kalwaney, S., Saab, S., & Younossi, Z. M. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0407-y · Cited by 32
Self-citationRepublished: Non-alcoholic fatty liver disease: a practical approach to treatment
Dyson, J. K., Anstee, Q. M., & McPherson, S. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-100404rep · Cited by 26
Self-citationDe Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation†
Abdelmalek, M. F., & Diehl, A. M. (2007) · Liver Transplantation · doi:10.1002/lt.21103 · Cited by 23
Self-citationPosttransplant metabolic syndrome: New evidence of an epidemic and recommendations for management
Satapathy, S. K., & Charlton, M. (2010) · Liver Transplantation · doi:10.1002/lt.22222 · Cited by 19
Self-citation
Cited by
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149
Self-citationGlobal perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858
Self-citationLonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., & Suzuki, A. (2019) · Hepatology · doi:10.1002/hep.30626 · Cited by 1,050
Self-citationStefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future
Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430
Self-citation
Metadata
- Authors
- Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander‐Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Chalasani, N. P., Anstee, Q. M., Kowdley, K. V., George, J., Goodman, Z. D., & Lindor, K.
- Venue
- Hepatology
- Published
- 2018-07
- Volume
- 68
- Issue
- 1
- Pages
- 361-371
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2773466959
- Cited by
- 357
- References
- 73
- FWCI
- 28.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.